C4 Therapeutics vs Cue Biopharma, .
C4 Therapeutics vs Cue Biopharma, ., compared side by side on 16 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: C4 Therapeutics is on 49/100 and Cue Biopharma, . on 62/100.
Where each one leads
C4 Therapeutics
- domain rating: 41/100 against 34/100
- funding raised: $371M against $10.0M
Cue Biopharma, .
- our overall score: 62/100 against 49/100
- agent readiness: 42/100 against 21/100
At a glance
| Measure | C4 Therapeutics | Cue Biopharma, . |
|---|---|---|
| What it is | Biopharmaceutical company developing novel cancer therapies using targeted protein degradation. | Developing engineered biologics to harness the immune system for disease treatment. |
| Category | Biotech, Drug Discovery, Oncology, Clinical Trials | Biotech, Drug Discovery, Immunotherapy, Therapeutics |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Biotech |
| Founded | 2016 | 2017 |
| Headquarters | Boston, United States | Boston, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | C4 Therapeutics | Cue Biopharma, . |
|---|---|---|
| Employees | Not published | 38 |
| Total funding | $371M | $10.0M |
| Latest round | Series D | Seed |
| LinkedIn followers | Not published | 5,297 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | C4 Therapeutics | Cue Biopharma, . |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 49/100 | 62/100 |
| Traction | 40/100 | Not published |
| Team | 20/100 | 60/100 |
| Search visibility | 3/100 | 67/100 |
| Quality | 68/100 | Not published |
| Agent readinessHow well an AI agent can read and act on the site | F (21/100) | D (42/100) |
| Domain ratingLink authority, 0-100 | 41/100 | 34/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | C4 Therapeutics | Cue Biopharma, . |
|---|---|---|
| Hosting | Google Cloud | Not detected |
| CDN | Not detected | Cloudflare |
| CMS | WordPress | WordPress |
| Frameworks | Not detected | Tailwind CSS |
| Analytics | Google Analytics 4, Google Tag Manager | Google Analytics 4 |
C4 Therapeutics vs Cue Biopharma, .: common questions
Which is better, C4 Therapeutics or Cue Biopharma, .?
On our 0-100 score Cue Biopharma, . rates higher (62/100 against 49/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 16 data points above: read the rows that match what you are buying for.
How do C4 Therapeutics and Cue Biopharma, . compare on the numbers?
C4 Therapeutics leads on domain rating (41/100 against 34/100), funding raised ($371M against $10.0M). Cue Biopharma, . leads on our overall score (62/100 against 49/100), agent readiness (42/100 against 21/100).
Read the full C4 Therapeutics review and pricing or the Cue Biopharma, . review and pricing. You can also browse other C4 Therapeutics alternatives we track.